Literature DB >> 12612449

Tryptanthrin inhibits interferon-gamma production by Peyer's patch lymphocytes derived from mice that had been orally administered staphylococcal enterotoxin.

Yasuhiko Takei1, Toshio Kunikata, Miho Aga, Shin-ichiro Inoue, Shimpei Ushio, Kanso Iwaki, Masao Ikeda, Masashi Kurimoto.   

Abstract

Tryptanthrin, a biologically active compound found in the medicinal plant Polygonum tinctorium, reportedly has several biological activities. We investigated the effects of tryptanthrin on cytokine production by lymphocytes in response to staphylococcal enterotoxin B (SEB), which causes a variety of disorders in humans based on its induction of large amounts of immunostimulatory cytokines. Tryptanthrin dose-dependently inhibited interferon-gamma (IFN-gamma) and interleukin-2 production by mouse spleen cells and Peyer's patch (PP) lymphocytes in vitro. The efficacy of tryptanthrin was further studied in a mouse model in vivo. Tryptanthrin was administered orally 2 h after an oral challenge with SEB. Nineteen hours after SEB administration, PP lymphocytes were prepared, and IFN-gamma production by PP lymphocytes was examined. The production of IFN-gamma increased after SEB administration, and the elevated IFN-gamma production was significantly inhibited by tryptanthrin treatment. These results suggest that tryptanthrin may be effective in the treatment of disorders of the intestines, such as food poisoning, that are associated with activated lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12612449     DOI: 10.1248/bpb.26.365

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  14 in total

1.  On the inhibition of 5-lipoxygenase product formation by tryptanthrin: mechanistic studies and efficacy in vivo.

Authors:  C Pergola; B Jazzar; A Rossi; H Northoff; M Hamburger; L Sautebin; O Werz
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 2.  The Malassezia genus in skin and systemic diseases.

Authors:  Georgios Gaitanis; Prokopios Magiatis; Markus Hantschke; Ioannis D Bassukas; Aristea Velegraki
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

3.  Proliferation-attenuating and apoptosis-inducing effects of tryptanthrin on human chronic myeloid leukemia K562 cell line in vitro.

Authors:  Shan Miao; Xiaopeng Shi; Hai Zhang; Siwang Wang; Jiyuan Sun; Wei Hua; Qing Miao; Yong Zhao; Caiqin Zhang
Journal:  Int J Mol Sci       Date:  2011-06-10       Impact factor: 5.923

Review 4.  The staphylococcal enterotoxin (SE) family: SEB and siblings.

Authors:  Teresa Krakauer; Bradley G Stiles
Journal:  Virulence       Date:  2013-04-19       Impact factor: 5.882

5.  The synthetic tryptanthrin analogue suppresses STAT3 signaling and induces caspase dependent apoptosis via ERK up regulation in human leukemia HL-60 cells.

Authors:  Anup S Pathania; Suresh Kumar; Santosh K Guru; Shashi Bhushan; Parduman R Sharma; Sravan K Aithagani; Parvinder P Singh; Ram A Vishwakarma; Ajay Kumar; Fayaz Malik
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

6.  Study on pharmacokinetics and tissue distribution of single dose oral tryptanthrin in Kunming mice by validated reversed-phase high-performance liquid chromatography with ultraviolet detection.

Authors:  Xiaoyan Zhang; Jie Xia; Wenjing Zhang; Yao Luo; Wenbo Sun; Wei Zhou
Journal:  Integr Med Res       Date:  2017-05-25

Review 7.  Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors.

Authors:  Bilal Zulfiqar; Amnah Mahroo; Kaenat Nasir; Rai Khalid Farooq; Nasir Jalal; Muhammad Usman Rashid; Kashif Asghar
Journal:  Onco Targets Ther       Date:  2017-01-21       Impact factor: 4.147

Review 8.  PI3K/Akt/mTOR, a pathway less recognized for staphylococcal superantigen-induced toxicity.

Authors:  Teresa Krakauer
Journal:  Toxins (Basel)       Date:  2012-11-15       Impact factor: 4.546

9.  Novel FeII and CoII Complexes of Natural Product Tryptanthrin: Synthesis and Binding with G-Quadruplex DNA.

Authors:  Yi-Ning Zhong; Yan Zhang; Yun-Qiong Gu; Shi-Yun Wu; Wen-Ying Shen; Ming-Xiong Tan
Journal:  Bioinorg Chem Appl       Date:  2016-09-06       Impact factor: 7.778

10.  Clinical efficacy and IL-17 targeting mechanism of Indigo naturalis as a topical agent in moderate psoriasis.

Authors:  Hui-Man Cheng; Yang-Chang Wu; Qingmin Wang; Michael Song; Jackson Wu; Dion Chen; Katherine Li; Eric Wadman; Shung-Te Kao; Tsai-Chung Li; Francisco Leon; Karen Hayden; Carrie Brodmerkel; C Chris Huang
Journal:  BMC Complement Altern Med       Date:  2017-09-02       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.